Technology News and Research

RSS

MRG: Preliminary results from CREST will increase growth in carotid stenting procedures

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, recent preliminary results from the CREST (Carotid Revascularization Endarterectomy versus Stenting Trial) will support growth in carotid stenting procedures of more than 10% over the next five years. The results were announced last week at the American Stroke Association International Stroke Conference 2010.

3 Mar 2010

Biomagnetics Diagnostics announces accelerated delivery timetable for integrated optical biosensor

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced its accelerated timetable for delivery of the world's first handheld, integrated optical biosensor.

3 Mar 2010

Pioneering stem cell research could revolutionize treatments for diabetes and Alzheimer's disease

A heart patient's own skin cells soon could be used to repair damaged cardiac tissue thanks to pioneering stem cell research of the University of Houston's newest biomedical scientist, Robert Schwartz.

3 Mar 2010

Vidacare's OnControl Bone Marrow System now available for bone marrow procedures

For many cancer patients, a bone marrow biopsy and/or aspiration is one of the most dreaded aspects of their diagnosis and treatment plan. The traditional method for gaining bone marrow involves grinding a needle by hand and sheer force through a patient’s skin and bone, and the procedure is often described as “brutal,” “excruciating” and even “barbaric.”

3 Mar 2010

Cyntellect to provide LEAP Cell Processing Workstation to Harvard University and HHMI researchers

Cyntellect, Inc., a privately-held life sciences company commercializing products to advance the study of cell biology, stem cell research, biopharmaceutical production, and drug discovery, has entered into an agreement with Harvard University and the Howard Hughes Medical Institute to provide their researchers with the LEAP™ Cell Processing Workstation.

3 Mar 2010

Ichor, Profectus announce agreement for clinical development of DNA vaccine programs

Ichor Medical Systems (Ichor) and Profectus Biosciences (Profectus) announced today that they have entered into a long-term development, license, and supply Agreement providing Profectus with commercial access to Ichor’s TriGrid™ Delivery System (TriGrid™) for the clinical development of its DNA vaccine programs, with an option for Ichor to co-develop.

3 Mar 2010

TechniScan launches clinical study to assess clinical utility of Warm Bath Ultrasound

TechniScan, Inc., a medical device company engaged in the development and commercialization of an automated 3-D breast ultrasound imaging system, today announced that in collaboration with University Medical Center Freiburg in Germany, it has launched a clinical study to assess clinical utility of TechniScan's Warm Bath Ultrasound.

3 Mar 2010

Major tech firms join ranks of health IT squad

"The race to streamline online access to medical records turned into a stampede this week as leading high-tech vendors trumpeted new initiatives at the Health Information and Management Systems Society" (HIMSS) trade show in Atlanta," InternetNews.com/Datamation reports, adding that Dell, Google, IBM, Microsoft and others are touting "new and pending deals designed to help consumers, doctors and hospital move to more easily accessible, but also secure, medical histories and information online" (Needle, 3/1).

3 Mar 2010

OrthoDynamix' ArthroSteer 3.5mm Ablator for general surgical use receives FDA clearance

OrthoDynamix announced today that it has received FDA clearance for its new device, ArthroSteer 3.5mm Ablator, a mono polar electrosurgical device, for general surgical use, including the orthopedic and arthroscopic applications for resection, ablation, excision of soft tissue, hemostasis of blood vessels, and coagulating soft tissue in, but not limited to the knee, shoulder, and primarily the hip.

3 Mar 2010

Advanced Cell Technology’s MA09-hRPE cells for treatment of SMD: FDA grants orphan drug designation

Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company’s MA09-hRPE cells for use in the treatment of Stargardt’s Macular Dystrophy (SMD). As a result, the company is eligible to receive a number of benefits, including tax credits, access to grant funding for clinical trials, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of as long as seven years.

3 Mar 2010

Amedica awarded U.S patent for advance bearing technology

Amedica Corporation, a spinal and orthopaedic implant and instrument company focused on unique silicon nitride (SiN) ceramic technologies, announced today that it has been granted United States Patent No. 7,666,229 covering its novel ceramic-on-ceramic bearings for articulating joints used for total joint replacement and spinal disc applications.

2 Mar 2010

Biomoda receives U.S patent for cancer and pre-cancer cell based diagnostic assay

Biomoda, Inc. (www.biomoda.com) was today awarded U.S. patent 7,670,799, entitled, "Composition and Method for Making 5, 10, 15, 20- Tetrakis (Carboxyphenyl) Porphine (TCPP)" directed to Biomoda's proprietary TCPP formulation for cancer and pre-cancer cell identification and analysis and a method of making the TCPP formulation.

2 Mar 2010

Affymetrix introduces GeneAtlas System for processing arrays and characterizing changes in gene expression

Affymetrix, Inc. today announced the launch of the GeneAtlas™ System, a complete, personal solution for processing Affymetrix arrays and characterizing changes in gene expression in a variety of research applications.

2 Mar 2010

Cleveland HeartLab completes $3.0M fundraising round

Cleveland HeartLab LLC (CHL) today announced that it has completed a $3.0-million fundraising round. The company’s new shareholders include local business leaders, and Glengary LLC, Second Generation Ltd. and Zapis Capital Group LLC.

2 Mar 2010

Merge Healthcare introduces new mobile device application for eFilm Workstation v3.3

Merge Healthcare, a leading health IT solutions provider, today announced the release of eFilm Mobile, an exciting new extension of the eFilm Workstation franchise.

2 Mar 2010

NJIT researcher awarded patent for functional coating compositions of perfluoroalkyl perfluoro-phthalocyanine compounds

Sergiu M. Gorun, PhD, associate professor of chemistry at New Jersey Institute of Technology (NJIT), was awarded a patent today for a novel composition of matter. “Functional Coating Compositions of Perfluoroalkyl Perfluoro-Phthalocyanine Compounds” (US Patent Number 7,670,684) discloses a new self-contained subclass of molecules.

2 Mar 2010

Supercomputer receives powerful supercomputer for biomedical and life sciences research from IBM

Rice University and IBM today unveiled a new high-performance computing initiative for biomedical and life sciences research that features one of the most powerful supercomputers in the Texas Medical Center. Rice scientists will use the supercomputer in collaboration with researchers from across the medical center to study cancer, AIDS and other complex diseases.

2 Mar 2010

ArQule reports net loss of $36,136,000 for 2009

ArQule, Inc. today announced its financial results for the year and for the fourth quarter ended December 31, 2009.

2 Mar 2010

Use of at-home medical devices can help patients and physicians efficiently manage chronic conditions

The use of at-home medical devices to connect doctors and patients via the Internet can help patients and their physicians work more efficiently together to manage chronic conditions, according to research at Cleveland Clinic.

2 Mar 2010

Sanquin Blood Supply Foundation, Netherlands Vaccine Institute launch AmpVacs project to develop influenza A vaccine

Sanquin Blood Supply Foundation, the Netherlands Cancer Institute, and the Netherlands Vaccine Institute announce today the launch of their joint AmpVacs project aiming at the development of a broadly protective synthetic influenza A vaccine component that in combination with classical antibody-stimulating vaccines will induce protection against future influenza A threats.

2 Mar 2010

Technology News and Research

MRG: Preliminary results from CREST will increase growth in carotid stenting procedures

Biomagnetics Diagnostics announces accelerated delivery timetable for integrated optical biosensor

Pioneering stem cell research could revolutionize treatments for diabetes and Alzheimer's disease

Vidacare's OnControl Bone Marrow System now available for bone marrow procedures

Cyntellect to provide LEAP Cell Processing Workstation to Harvard University and HHMI researchers

Ichor, Profectus announce agreement for clinical development of DNA vaccine programs

TechniScan launches clinical study to assess clinical utility of Warm Bath Ultrasound

Major tech firms join ranks of health IT squad

OrthoDynamix' ArthroSteer 3.5mm Ablator for general surgical use receives FDA clearance

Advanced Cell Technology’s MA09-hRPE cells for treatment of SMD: FDA grants orphan drug designation

Amedica awarded U.S patent for advance bearing technology

Biomoda receives U.S patent for cancer and pre-cancer cell based diagnostic assay

Affymetrix introduces GeneAtlas System for processing arrays and characterizing changes in gene expression

Cleveland HeartLab completes $3.0M fundraising round

Merge Healthcare introduces new mobile device application for eFilm Workstation v3.3

NJIT researcher awarded patent for functional coating compositions of perfluoroalkyl perfluoro-phthalocyanine compounds

Supercomputer receives powerful supercomputer for biomedical and life sciences research from IBM

ArQule reports net loss of $36,136,000 for 2009

Use of at-home medical devices can help patients and physicians efficiently manage chronic conditions

Sanquin Blood Supply Foundation, Netherlands Vaccine Institute launch AmpVacs project to develop influenza A vaccine

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News